| 1 |
31993732 | Rasagiline and selegiline modulate mitochondrial homeostasis, intervene apoptosis system and mitigate α-synuclein cytotoxicity in disease-modifying therapy for Parkinson's disease. | 2020 Feb |
1 |
| 2 |
29279995 | Type A and B monoamine oxidases distinctly modulate signal transduction pathway and gene expression to regulate brain function and survival of neurons. | 2018 Nov |
1 |
| 3 |
28577058 | Type B and A monoamine oxidase and their inhibitors regulate the gene expression of Bcl-2 and neurotrophic factors in human glioblastoma U118MG cells: different signal pathways for neuroprotection by selegiline and rasagiline. | 2017 Sep |
2 |
| 4 |
25832828 | A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: Possible mitochondrial biomarker target engagement. | 2015 |
1 |
| 5 |
22892822 | ''70th Birthday Professor Riederer'' induction of glial cell line-derived and brain-derived neurotrophic factors by rasagiline and (-)deprenyl: a way to a disease-modifying therapy? | 2013 Jan |
1 |
| 6 |
22968599 | Rasagiline and selegiline, inhibitors of type B monoamine oxidase, induce type A monoamine oxidase in human SH-SY5Y cells. | 2013 Mar |
2 |
| 7 |
23739004 | Revelation in the neuroprotective functions of rasagiline and selegiline: the induction of distinct genes by different mechanisms. | 2013 Jun |
1 |
| 8 |
22065207 | Type A monoamine oxidase is associated with induction of neuroprotective Bcl-2 by rasagiline, an inhibitor of type B monoamine oxidase. | 2012 Apr |
6 |
| 9 |
19763773 | Mitochondria in neurodegenerative disorders: regulation of the redox state and death signaling leading to neuronal death and survival. | 2009 Nov |
1 |
| 10 |
17982885 | Neuroprotection by propargylamines in Parkinson's disease: intracellular mechanism underlying the anti-apoptotic function and search for clinical markers. | 2007 |
1 |
| 11 |
17447417 | Involvement of type A monoamine oxidase in neurodegeneration: regulation of mitochondrial signaling leading to cell death or neuroprotection. | 2006 |
1 |
| 12 |
15850677 | Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives. | 2005 Apr |
1 |
| 13 |
16148027 | Regulation of Bcl-2 family proteins, neurotrophic factors, and APP processing in the neurorescue activity of propargylamine. | 2005 Nov |
1 |
| 14 |
14555244 | The essentiality of Bcl-2, PKC and proteasome-ubiquitin complex activations in the neuroprotective-antiapoptotic action of the anti-Parkinson drug, rasagiline. | 2003 Oct 15 |
3 |
| 15 |
12057839 | An anti-Parkinson's disease drug, N-propargyl-1(R)-aminoindan (rasagiline), enhances expression of anti-apoptotic bcl-2 in human dopaminergic SH-SY5Y cells. | 2002 Jun 28 |
4 |
| 16 |
12200198 | Neuroprotection by propargylamines in Parkinson's disease: suppression of apoptosis and induction of prosurvival genes. | 2002 Sep-Oct |
1 |